Please do not leave this page until complete. This can take a few moments.
Pharmacy giant CVS Health, which bought Hartford-based Aetna in 2018, said company profits increased nearly 54% in the second quarter, an increase of more than $1 billion, thanks mainly to an unprecedented drop in health insurance payments fueled by COVID-19.
CVS reported $2.98 billion in profit, or $2.26 per diluted share, for the quarter ended June 30, up from $1.94 billion, or $1.49, in the same quarter of 2019.
The results beat analyst forecasts compiled by Zacks Investment Research, and CVS increased its full-year guidance to $5.59 to $5.72 per share, up from a prior range of $5.47 to $5.60.
"We're a health innovation company that is built to meet the evolving needs of the millions we serve every day,” CVS Health President and CEO Larry J. Merlo said in a statement. “That's been made clear as we continue to navigate the health, social and economic impacts of COVID-19. Our earnings in this environment demonstrate the strength of our strategy and the power of our diversified business model.”
CVS’ health benefits segment, which includes the Aetna business, saw benefit costs for the quarter fall by more than 10%, from $13.09 billion to $11.75 billion, as the pandemic discouraged patients from going to the doctor and forced hospitals to cancel elective surgeries.
Meanwhile, premium revenue for that segment grew by more than 7%, or $1.1 billion, during the quarter, fueled by membership increases in Medicare and Medicaid products. The gains were partially offset by an approximately 2% year-over-year decline in commercial health plan membership, as unemployment rates rose across the country.
“We had anticipated more losses in commercial than we saw in the second quarter,” Aetna President Karen Lynch told analysts on an earnings call Wednesday morning. “We do think that’s related to companies doing more furloughs than eliminating jobs. However, as we turn the corner for the rest of the year, we anticipate we’ll see continued commercial losses due to unemployment.”
The drop in healthcare utilization experienced in the recent quarter is also not expected to last for the remainder of the year.
Lynch said CVS is projecting more normal levels of utilization in the second half of the year, with some fluctuations in areas of the country experiencing renewed waves of the virus.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments